Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 317357011000036119 | aluminium hydroxide 200 mg / 5 mL + magnesium hydroxide 200 mg / 5 mL + simethicone 20 mg / 5 mL oral liquid, 500 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 563911000036112 | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | has MPUU | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylanta P Antacid oral liquid, 500 mL | Is a | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | Inferred relationship | Some | |
| Gelusil oral liquid, 500 mL | Is a | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | Inferred relationship | Some | |
| Mylanta Original oral liquid, 500 mL | Is a | True | aluminium hydroxide 200 mg/5 mL + magnesium hydroxide 200 mg/5 mL + simethicone 20 mg/5 mL oral liquid, 500 mL | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR